"10.1371_journal.pone.0121952","plos one","2015-03-25T00:00:00Z","Mary Louise Lindegren; Marie R Griffin; John V Williams; Kathryn M Edwards; Yuwei Zhu; Ed Mitchel; Alicia M Fry; William Schaffner; H Keipp Talbot","Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Mid-South Geriatric Research Education and Clinical Center, VA TN Valley Health Care System, Nashville, Tennessee, United States of America; Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America","Conceived and designed the experiments: MLL MRG JVW KME YZ EM AMF WS HKT. Performed the experiments: MLL MRG JVW KME YZ EM AMF WS HKT. Analyzed the data: MLL MRG JVW KME YZ EM AMF WS HKT. Contributed reagents/materials/analysis tools: MLL MRG JVW KME YZ EM AMF WS HKT. Wrote the paper: MLL MRG JVW KME YZ EM AMF WS HKT.","HKBT has received research funds from Protein Sciences, Vaxinnate, Sanofi Pasteur, Medimmune/AstraZeneca, and Wyeth and serves as an advisor for Teva. MRG has received research funds from Medimmune and the CDC. KME is conducting a study of an unrelated vaccine supported by Novartis and is a member of an influenza vaccine DSMB supported by Novartis. MLL, EM, AF, YZ have no conflicts of interest. JVW serves on the Scientific Advisory Board of Quidel. WS is a member of a Data Safety Monitoring Board for Merck and is an occasional consultant to Sanofi-Pasteur, Pfizer and Dynavox. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","03","Mary Louise Lindegren","MLL",9,TRUE,9,9,9,9,TRUE,TRUE,FALSE,0,NA,FALSE
